D Abigerges
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- Toxicology top 5%
Papers in
- Oncology 10
- Lung Cancer Research Studies 7
- Neutropenia and Cancer Infections 4
- HER2/EGFR in Cancer Research 1
- Cancer Treatment and Pharmacology 1
- Colorectal Cancer Treatments and Studies 1
-
- Cancer therapeutics and mechanisms 8
- Co-authors
- Patrice Herait (6 shared papers)G G Chabot (5 shared papers)Jean‐Pierre Armand (7 shared papers)Daniel Gandía (3 shared papers)Alain Gouyette (1 shared paper)P. Armand (2 shared papers)M. Mahjoubi (3 shared papers)R. Bugat (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)European Journal of Cancer (3 papers)Annals of Oncology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
D Abigerges
12 papers receiving 800 citations
Peers
Comparison fields: 5 of 63
- Oncology 669
- Toxicology 37
- Hepatology 79
- Molecular Biology 607
- Pharmacology 74
Countries citing papers authored by D Abigerges
This map shows the geographic impact of D Abigerges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Abigerges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Abigerges more than expected).
Fields of papers citing papers by D Abigerges
This network shows the impact of papers produced by D Abigerges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Abigerges. The network helps show where D Abigerges may publish in the future.
Co-authors
The 25 scholars most cited alongside D Abigerges, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 249 | |
| 2 | 1994 | 215 | |
| 3 | 1995 | 149 | |
| 4 | 1995 | 97 | |
| 5 | 1997 | 48 | |
| 6 | 1996 | 29 | |
| 7 | 1996 | 23 | |
| 8 | 1993 | 12 | |
| 9 | 2006 | 2 | |
| 10 | 2016 | 1 | |
| 11 | 1996 | 1 | |
| 12 | 1993 | 1 |
About D Abigerges
D Abigerges is a scholar working on Oncology, Molecular Biology, Neurology, Pulmonary and Respiratory Medicine and Organic Chemistry, having authored 12 papers that have together received 827 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Lung Cancer Research Studies (7 papers), Neutropenia and Cancer Infections (4 papers), Neuroblastoma Research and Treatments (3 papers), Lung Cancer Treatments and Mutations (2 papers), HER2/EGFR in Cancer Research (1 paper), Cancer Treatment and Pharmacology (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (669 citations), Toxicology (37 citations), Hepatology (79 citations), Molecular Biology (607 citations) and Pharmacology (74 citations). D Abigerges has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Patrice Herait, G G Chabot, Jean‐Pierre Armand, Daniel Gandía, Alain Gouyette, P. Armand, M. Mahjoubi, R. Bugat, Élie Fadel and Claudia Côté. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, JNCI Journal of the National Cancer Institute and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.